Untangling the cell immune response dynamic for severe and critical cases of SARS-CoV-2 infection
Abstract
COVID-19 is a global pandemic leading high death tolls worldwide day by day. Clinical evidence suggests that COVID-19 patients can be classified as non-severe, severe and critical cases. In particular, studies have highlighted the relationship between the lymphopenia and the severity of the illness, where CD8+ T cells have the lowest levels in critical cases. In this work, we aim to elucidate the key parameters that define the course of the disease deviating from severe to critical case. To this end, several mathematical models are proposed to represent the dynamic of the immune response in patients with SARS-CoV-2 infection. The best model had a good fit to reported experimental data, and in accordance with values found in the literature. Our results suggest that a rapid proliferation of CD8+ T cells is decisive in the severity of the disease.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets
S. Matic, S. Popovic, … D. Baskic·bioRxiv·Oct 9, 2020
- Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19
S. Adamo, S. Chevrier, … J. Nilsson·bioRxiv·Aug 4, 2020
- COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes
A. L. Jenner, R. A. Aogo, … M. Craig·bioRxiv·Jan 5, 2021
- The peripheral T cell population is associated with pneumonia severity in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus 2
N. Nagata, N. Iwata-Yoshikawa, … H. Hasegawa·bioRxiv·Jan 7, 2021
- The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H. Bolouri, C. Speake, … BRI COVID-19 Research Team·bioRxiv·Sep 18, 2020
- Mechanistic modeling of the SARS-CoV-2 and immune system interplay unravels design principles for diverse clinicopathological outcomes
Sarthak Sahoo, Kishore Hari, … Mohit Kumar Jolly·bioRxiv·May 16, 2020